192 related articles for article (PubMed ID: 33387918)
1. Use of ring-enhancement and focal necrosis to differentiate pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma on CT and MRI.
Schawkat K; Tsai LL; Jaramillo-Cardoso A; Paez SN; Moser JA; Decicco C; Singer T; Glickman J; Brook A; Manning MA; Mortele KJ
Clin Imaging; 2021 May; 73():134-138. PubMed ID: 33387918
[TBL] [Abstract][Full Text] [Related]
2. Adenosquamous carcinoma of pancreas: CT and MR imaging features in eight patients, with pathologic correlations and comparison with adenocarcinoma of pancreas.
Toshima F; Inoue D; Yoshida K; Yoneda N; Minami T; Kobayashi S; Ikdeda H; Matsui O; Gabata T
Abdom Radiol (NY); 2016 Mar; 41(3):508-20. PubMed ID: 27039322
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced multiphasic CT and MRI findings of adenosquamous carcinoma of the pancreas.
Ding Y; Zhou J; Sun H; He D; Zeng M; Rao S
Clin Imaging; 2013; 37(6):1054-60. PubMed ID: 24035524
[TBL] [Abstract][Full Text] [Related]
4. Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal Adenocarcinoma.
Ren S; Tang HJ; Zhao R; Duan SF; Chen R; Wang ZQ
Curr Med Sci; 2022 Feb; 42(1):217-225. PubMed ID: 35089491
[TBL] [Abstract][Full Text] [Related]
5. Ring-enhancement pattern on contrast-enhanced CT predicts adenosquamous carcinoma of the pancreas: a matched case-control study.
Imaoka H; Shimizu Y; Mizuno N; Hara K; Hijioka S; Tajika M; Tanaka T; Ishihara M; Ogura T; Obayashi T; Shinagawa A; Sakaguchi M; Yamaura H; Kato M; Niwa Y; Yamao K
Pancreatology; 2014; 14(3):221-6. PubMed ID: 24854619
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens.
Ma C; Yang P; Li J; Bian Y; Wang L; Lu J
Abdom Radiol (NY); 2020 Mar; 45(3):782-788. PubMed ID: 31292672
[TBL] [Abstract][Full Text] [Related]
7. Impact of structured report on the quality of preoperative CT staging of pancreatic ductal adenocarcinoma: assessment of intra- and inter-reader variability.
Dimarco M; Cannella R; Pellegrino S; Iadicola D; Tutino R; Allegra F; Castiglione D; Salvaggio G; Midiri M; Brancatelli G; Vernuccio F
Abdom Radiol (NY); 2020 Feb; 45(2):437-448. PubMed ID: 31686180
[TBL] [Abstract][Full Text] [Related]
8. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
[No Abstract] [Full Text] [Related]
9. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Lee S; Kim JH; Kim SY; Byun JH; Kim HJ; Kim MH; Lee MG; Lee SS
Eur Radiol; 2018 Dec; 28(12):5267-5274. PubMed ID: 29948075
[TBL] [Abstract][Full Text] [Related]
10. Large Duct Pancreatic Ductal Adenocarcinoma: A Morphological Variant of Pancreatic Ductal Adenocarcinoma With Distinct CT and MRI Characteristics.
Choi SJ; Kim SJ; Kim DW; Lee SS; Hong SM; Kim KW; Kim JH; Kim HJ; Byun JH
Korean J Radiol; 2023 Dec; 24(12):1232-1240. PubMed ID: 38016682
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping.
Kim M; Jang KM; Kim JH; Jeong WK; Kim SH; Kang TW; Kim YK; Cha DI; Kim K
Eur Radiol; 2017 Apr; 27(4):1722-1732. PubMed ID: 27510628
[TBL] [Abstract][Full Text] [Related]
12. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.
Guo C; Zhuge X; Wang Q; Xiao W; Wang Z; Wang Z; Feng Z; Chen X
Cancer Imaging; 2018 Oct; 18(1):37. PubMed ID: 30333055
[TBL] [Abstract][Full Text] [Related]
13. Fully automated magnetic resonance imaging-based radiomics analysis for differentiating pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma.
Li Q; Zhou Z; Chen Y; Yu J; Zhang H; Meng Y; Zhu M; Li N; Zhou J; Liu F; Fang X; Li J; Wang T; Lu J; Zhang T; Xu J; Shao C; Bian Y
Abdom Radiol (NY); 2023 Jun; 48(6):2074-2084. PubMed ID: 36964775
[TBL] [Abstract][Full Text] [Related]
14. Adenosquamous carcinoma of the pancreas: multidetector-row computed tomographic manifestations and tumor characteristics.
Yin Q; Wang C; Wu Z; Wang M; Cheng K; Zhao X; Yuan F; Tang Y; Miao F
J Comput Assist Tomogr; 2013; 37(2):125-33. PubMed ID: 23493198
[TBL] [Abstract][Full Text] [Related]
15. Small solid tumors (< or = 2 cm) of the pancreas: relative accuracy and differentiation of CT and MR imaging.
Rao SX; Zeng MS; Cheng WZ; Yao XZ; Jin DY; Ji Y
Hepatogastroenterology; 2011; 58(107-108):996-1001. PubMed ID: 21830431
[TBL] [Abstract][Full Text] [Related]
16. Adding Delayed Phase Images to Dual-Phase Contrast-Enhanced CT Increases Sensitivity for Small Pancreatic Ductal Adenocarcinoma.
Fukukura Y; Kumagae Y; Fujisaki Y; Yamagishi R; Nakamura S; Kamizono J; Nakajo M; Kamimura K; Nagano H; Takumi K; Yoshiura T
AJR Am J Roentgenol; 2021 Oct; 217(4):888-897. PubMed ID: 33759561
[No Abstract] [Full Text] [Related]
17. CT and MR imaging features of pancreatic adenosquamous carcinoma and their correlation with prognosis.
Zhao R; Jia Z; Chen X; Ren S; Cui W; Zhao DL; Wang S; Wang J; Li T; Zhu Y; Tang X; Wang Z
Abdom Radiol (NY); 2019 Aug; 44(8):2822-2834. PubMed ID: 31187197
[TBL] [Abstract][Full Text] [Related]
18. Can we rely on contrast-enhanced CT to identify pancreatic ductal adenocarcinoma? A population-based study in sensitivity and factors associated with false negatives.
LeBlanc M; Kang J; Costa AF
Eur Radiol; 2023 Nov; 33(11):7656-7664. PubMed ID: 37266655
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
[TBL] [Abstract][Full Text] [Related]
20. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
[No Abstract] [Full Text] [Related]
[Next] [New Search]
